GSA Capital Partners’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

GSA Capital Partners’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,094	Closed	-$98K	–	2022
2022 Q3	$98K	Buy	14,094 +1,156	+9%	+$8.63K	0.01%	1367
2022 Q2	$90K	Buy	12,938 +1,543	+14%	+$12K	0.01%	1238
2022 Q1	$94K	Buy	+11,395	New	+$103K	0.01%	1300

Other funds holding AMYT

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

GSA Capital Partners's AMYT Position: Q4 2022 in Review

GSA Capital Partners sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q4 2022, closing a stake of 14,094 shares — an estimated $98K sold.

GSA Capital Partners first reported a position in AMYT in Q1 2022 and held it in 3 quarters. The position peaked at $98K in Q3 2022. 57 funds tracked by Wall St. Rank hold AMYT as of Q4 2022.

GSA Capital Partners reported no remaining Amryt Pharma plc American Depositary Shares position as of Q4 2022 after selling out during the quarter.
GSA Capital Partners sold 14,094 Amryt Pharma plc American Depositary Shares shares in Q4 2022, an estimated $98K.
GSA Capital Partners first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2022 and held it in 3 quarters.
GSA Capital Partners's Amryt Pharma plc American Depositary Shares position peaked at $98K in Q3 2022.
57 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q4 2022.

Based on GSA Capital Partners's 13F filing for Q4 2022, filed 13 Feb 2023.